Home › Funds › Lynx1 Capital Management LP › KZIA
Lynx1 Capital Management LP position in KZIA
KAZIA THERAPEUTICS LTD · Health Care
Lynx1 Capital Management LP reported holding 225,800 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.34% of its reported portfolio and ranking #12 among its reported holdings. Lynx1 Capital Management LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's KZIA position evolved
Lynx1 Capital Management LP first disclosed a stake in KZIA in Q3 2026 at 225,800 shares (US$2.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 225.80K | $2.17M | New |
About KZIA and 13F data
KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 60 other funds we track also report a position in KZIA — the largest reported positions include Dauntless Investment Group, LLC (US$8.3M), Bleichroeder LP (US$4.7M), Stonepine Capital Management, LLC (US$3.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KZIA
- Dauntless Investment Group, LLC 866.22K sh · $8.31M · Q3 2026
- Bleichroeder LP 490.41K sh · $4.71M · Q3 2026
- Stonepine Capital Management, LLC 377.43K sh · $3.62M · Q3 2026
- Boxer Capital Management, LLC 371.50K sh · $3.56M · Q3 2026
- Knoll Capital Management, LLC 129.00K sh · $1.24M · Q3 2026
- Kalehua Capital Management LLC 56.01K sh · $537.45K · Q3 2026
- COOPERMAN LEON G 50.00K sh · $479.75K · Q3 2026
- ACT Capital Partners, L.P. 35.00K sh · $335.82K · Q3 2026
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held KZIA?
Lynx1 Capital Management LP has disclosed KZIA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Lynx1 Capital Management LP's current position in KZIA?
As of Q3 2026, Lynx1 Capital Management LP holds 225.80K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $2.17M, representing 0.34% of its reported portfolio and ranking #12.
Has Lynx1 Capital Management LP been buying or selling KZIA?
In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP newly opened its position in KZIA.
Which other funds hold KZIA?
Other major institutional holders of KZIA include Dauntless Investment Group, LLC, Bleichroeder LP, Stonepine Capital Management, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.